Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Inverse agonism of the CB1 receptor increases energy expenditure

June 11, 2003

Serotonin 5-HT6 receptor antagonism attenuates food intake and body weight

June 11, 2003

Novel glycogen phosphorylase inhibitors prepared and tested by JT researchers

June 11, 2003

D-003 prevents bone loss and reduces bone resorption in ovariectomized rats

June 11, 2003

The EP4 agonist Ono-4819 accelerates bone healing in rats

June 11, 2003

GlaxoSmithKline advances development of GW-501516

June 10, 2003

New PPARgamma receptor modulators in Sankyo development pipeline

June 10, 2003

New GenoMed trial for osteoporosis

June 6, 2003

CPMP grants positive opinion on new indication for Actos

June 6, 2003

DPP-IV inhibitors in Probiodrug development pipeline

June 6, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...